Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy

Gabriele Romano, Lawrence N. Kwong

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Cancer immunotherapy has shown impressive clinical results in the last decade, improving both solid and hematologic cancer patients’ overall survival. Nevertheless, most of the molecular aspects underlying the response to this approach are still under investigation. miRNAs in particular have been described as regulators of a plethora of different immunologic processes and thus have the potential to be key in the future developments of immunotherapy. In this review, we summarize and discuss the emerging role of miRNAs in the diagnosis and therapeutics of the four principal cancer immunotherapy approaches: immune checkpoint blockade, adoptive cell therapy, cancer vaccines, and cytokine therapy. In particular, this review is focused on potential roles for miRNAs to be adjuvants in soluble factor- and cell-based therapies, with the aim of helping to increase specificity and decrease toxicity, and on the potential for rationally identified miRNA-based diagnostic approaches to aid in precision clinical immunooncology.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalCancer and Metastasis Reviews
Volume37
Issue number1
DOIs
StatePublished - Mar 1 2018

Keywords

  • Cancer diagnostics
  • Cancer immunotherapy
  • Immune-based therapies
  • miRNAs

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy'. Together they form a unique fingerprint.

Cite this